Kathleen Borthwick

Finansdirektör/CFO på PASSAGE BIO, INC.

Förmögenhet: 31 170 $ per 2026-05-31

50 år

Health Technology

Consumer Services

Profil

Kathleen Borthwick is currently Chief Financial Officer at Passage Bio, Inc. since 2024.
Formerly, Ms. Borthwick was Head-Business Development at Johnson & Johnson Services, Inc. Education includes an MBA from Tuck School of Business at Dartmouth and an undergraduate degree from The Wharton School of the University of Pennsylvania.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
PASSAGE BIO, INC. 0,17 %	2026-03-16	5 402 ( 0,17 % )	31 170 $	2026-05-31

Aktiva positioner av Kathleen Borthwick

Företag	Position	Start
PASSAGE BIO, INC.	Finansdirektör/CFO	2023-07-28

Alla aktiva positioner av Kathleen Borthwick

Tidigare kända positioner av Kathleen Borthwick

Företag	Position	Slut
Johnson & Johnson Services, Inc. Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company	Företagsledare/Principal	-

Se detaljerna i Kathleen Borthwicks erfarenhet

Kathleen Borthwicks utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Kathleen Borthwicks erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Johnson & Johnson Services, Inc. Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company	Health Technology
Tuck School of Business at Dartmouth Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Passage Bio, Inc. Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders	Health Technology